Published in J Acquir Immune Defic Syndr on September 01, 2013
High Rates of STIs in HIV-Infected Patients Attending an STI Clinic. South Med J (2016) 0.75
Discordance between sexual behavior and self-reported sexual identity: a population-based survey of New York City men. Ann Intern Med (2006) 3.51
Reducing the risk of sexual HIV transmission: quantifying the per-act risk for HIV on the basis of choice of partner, sex act, and condom use. Sex Transm Dis (2002) 3.11
Heterosexual anal sex activity in the year after an STD clinic visit. Sex Transm Dis (2008) 2.59
Condom effectiveness for reducing transmission of gonorrhea and chlamydia: the importance of assessing partner infection status. Am J Epidemiol (2004) 2.49
Detecting unsuspected HIV infection with a rapid whole-blood HIV test in an urban emergency department. J Acquir Immune Defic Syndr (2007) 2.48
Use of the community viral load as a population-based biomarker of HIV burden. AIDS (2012) 2.31
Male circumcision and risk of HIV infection among heterosexual African American men attending Baltimore sexually transmitted disease clinics. J Infect Dis (2009) 2.22
Seroprevalence and correlates of herpes simplex virus type 2 infection in five sexually transmitted-disease clinics. J Infect Dis (2002) 2.08
Relative efficacy of prevention counseling with rapid and standard HIV testing: a randomized, controlled trial (RESPECT-2). Sex Transm Dis (2005) 2.03
Chlamydia trachomatis among patients infected with and treated for Neisseria gonorrhoeae in sexually transmitted disease clinics in the United States. Ann Intern Med (2003) 1.86
Incidence of herpes simplex virus type 2 infection in 5 sexually transmitted disease (STD) clinics and the effect of HIV/STD risk-reduction counseling. J Infect Dis (2004) 1.79
Dilemmas in the management of syphilis: a survey of infectious diseases experts. Clin Infect Dis (2009) 1.73
Seroprevalence and coinfection with herpes simplex virus type 1 and type 2 in the United States, 1988-1994. J Infect Dis (2002) 1.72
Misclassification of the stages of syphilis: implications for surveillance. Sex Transm Dis (2005) 1.66
Intention to notify sexual partners about potential HIV exposure among New York city STD clinics' clients. Sex Transm Dis (2002) 1.64
Economics of an adolescent meningococcal conjugate vaccination catch-up campaign in the United States. Clin Infect Dis (2008) 1.60
Men who have sex with men have a 140-fold higher risk for newly diagnosed HIV and syphilis compared with heterosexual men in New York City. J Acquir Immune Defic Syndr (2011) 1.57
HIV testing frequency among men who have sex with men attending sexually transmitted disease clinics: implications for HIV prevention and surveillance. J Acquir Immune Defic Syndr (2009) 1.55
Prevalence and correlates of HIV serostatus disclosure. Sex Transm Dis (2003) 1.47
Factors Associated With Hepatitis C Infection Among HIV-Infected Men Who Have Sex With Men With No Reported Injection Drug Use in New York City, 2000-2010. Sex Transm Dis (2015) 1.43
Risk factors for prevalent and incident Trichomonas vaginalis among women attending three sexually transmitted disease clinics. Sex Transm Dis (2008) 1.39
Sexually transmitted diseases program performance measures: how are they performing? Sex Transm Dis (2011) 1.39
Partner notification for gonorrhea-time for new ideas. Sex Transm Dis (2007) 1.38
A case-control study of syphilis among men who have sex with men in New York City: association With HIV infection. Sex Transm Dis (2004) 1.31
Changes in sexual behavior and STD prevalence among heterosexual STD clinic attendees: 1993-1995 versus 1999-2000. Sex Transm Dis (2007) 1.28
Extragenital gonorrhea and chlamydia testing and infection among men who have sex with men--STD Surveillance Network, United States, 2010-2012. Clin Infect Dis (2014) 1.25
Persistent, undetected Trichomonas vaginalis infections? Clin Infect Dis (2009) 1.25
Rapid HIV antibody testing in the New York State Anonymous HIV Counseling and Testing Program: experience from the field. J Acquir Immune Defic Syndr (2006) 1.24
Barriers and facilitators of linkage to HIV primary care in New York City. J Acquir Immune Defic Syndr (2013) 1.23
Serologic testing for syphilis in the United States: a cost-effectiveness analysis of two screening algorithms. Sex Transm Dis (2011) 1.22
Partner notification for HIV and syphilis: effects on sexual behaviors and relationship stability. Sex Transm Dis (2003) 1.20
Problems with condom use among patients attending sexually transmitted disease clinics: prevalence, predictors, and relation to incident gonorrhea and chlamydia. Am J Epidemiol (2007) 1.19
Is HIV/sexually transmitted disease prevention counseling effective among vulnerable populations?: a subset analysis of data collected for a randomized, controlled trial evaluating counseling efficacy (Project RESPECT). Sex Transm Dis (2004) 1.19
Male circumcision for prevention of HIV transmission: what the new data mean for HIV prevention in the United States. PLoS Med (2007) 1.18
HIV incidence among men with and those without sexually transmitted rectal infections: estimates from matching against an HIV case registry. Clin Infect Dis (2013) 1.18
Seroepidemiology of infection with human papillomavirus 16, in men and women attending sexually transmitted disease clinics in the United States. J Infect Dis (2004) 1.17
Deaths among people with hepatitis C in New York City, 2000-2011. Clin Infect Dis (2014) 1.17
Predictors of acceptance of hepatitis B vaccination in an urban sexually transmitted diseases clinic. Sex Transm Dis (2004) 1.17
Application of the case-crossover design to reduce unmeasured confounding in studies of condom effectiveness. Am J Epidemiol (2005) 1.16
Barriers to HIV testing among HIV/AIDS concurrently diagnosed persons in New York City. Sex Transm Dis (2011) 1.15
Increased HIV and primary and secondary syphilis diagnoses among young men--United States, 2004-2008. J Acquir Immune Defic Syndr (2011) 1.14
Extensive genetic diversity, unique population structure and evidence of genetic exchange in the sexually transmitted parasite Trichomonas vaginalis. PLoS Negl Trop Dis (2012) 1.14
Acceptability of Carraguard, a candidate microbicide and methyl cellulose placebo vaginal gels among HIV-positive women and men in Durban, South Africa. AIDS Res Ther (2007) 1.13
Trichomonas vaginalis antimicrobial drug resistance in 6 US cities, STD Surveillance Network, 2009-2010. Emerg Infect Dis (2012) 1.10
The importance of both sexual behavior and identity. Am J Public Health (2006) 1.09
Time to treatment for women with chlamydial or gonococcal infections: a comparative evaluation of sexually transmitted disease clinics in 3 US cities. Sex Transm Dis (2005) 1.07
Tolerance and efficacy of combined diethylcarbamazine and albendazole for treatment of Wuchereria bancrofti and intestinal helminth infections in Haitian children. Am J Trop Med Hyg (2005) 1.07
Averting HIV infections in New York City: a modeling approach estimating the future impact of additional behavioral and biomedical HIV prevention strategies. PLoS One (2013) 1.07
Seroprevalence of herpes simplex virus type 2 and characteristics associated with undiagnosed infection: New York City, 2004. Sex Transm Dis (2008) 1.06
Temporal association between expanded HIV testing and improvements in population-based HIV/AIDS clinical outcomes, District of Columbia. AIDS Care (2013) 1.06
Hospitalized HIV-infected patients in the era of highly active antiretroviral therapy. Am J Public Health (2009) 1.05
A stratified approach to untangling the behavioral/biomedical outcomes conundrum. Sex Transm Dis (2002) 1.05
Chlamydia trachomatis and Neisseria gonorrhoeae prevalence and coinfection in adolescents entering selected US juvenile detention centers, 1997-2002. Sex Transm Dis (2005) 1.04
Lymphogranuloma venereum in the industrialised world. Lancet (2005) 1.04
A Trich-y question: should Trichomonas vaginalis infection be reportable? Sex Transm Dis (2013) 1.02
Do women with persistently negative nontreponemal test results transmit syphilis during pregnancy? Sex Transm Dis (2013) 1.02
The program cost and cost-effectiveness of screening men for Chlamydia to prevent pelvic inflammatory disease in women. Sex Transm Dis (2008) 1.01
Depressive symptoms and sexual risk behavior in young, chlamydia-infected, heterosexual dyads. J Adolesc Health (2009) 1.00
Efficacy of a booster counseling session 6 months after HIV testing and counseling: a randomized, controlled trial (RESPECT-2). Sex Transm Dis (2005) 0.99
Linkage, engagement, and viral suppression rates among HIV-infected persons receiving care at medical case management programs in Washington, DC. J Acquir Immune Defic Syndr (2013) 0.99
Rate and predictors of repeat Chlamydia trachomatis infection among men. Sex Transm Dis (2008) 0.98
Sexual behaviors and sexual violence: adolescents with opposite-, same-, or both-sex partners. Pediatrics (2010) 0.98
Using STD electronic medical record data to drive public health program decisions in New York City. Am J Public Health (2010) 0.97
Elevated risk for invasive meningococcal disease among persons with HIV. Ann Intern Med (2014) 0.97
Phase I safety trial of two vaginal microbicide gels (Acidform or BufferGel) used with a diaphragm compared to KY jelly used with a diaphragm. Sex Transm Dis (2007) 0.96
Incident sexually transmitted infections among persons living with diagnosed HIV/AIDS in New York City, 2001-2002: a population-based assessment. Sex Transm Dis (2007) 0.96
The contribution of a urine-based jail screening program to citywide male Chlamydia and gonorrhea case rates in New York City. Sex Transm Dis (2009) 0.95
Aetiology of diarrhoea in a birth cohort of children aged 0-2 year(s) in rural Mirzapur, Bangladesh. J Health Popul Nutr (2006) 0.94
Vaginal microbicide and diaphragm use for sexually transmitted infection prevention: a randomized acceptability and feasibility study among high-risk women in Madagascar. Sex Transm Dis (2008) 0.94
Changes in partnerships and HIV risk behaviors after partner notification. Sex Transm Dis (2003) 0.94
Estimating Chlamydia screening rates by using reported sexually transmitted disease tests for sexually active women aged 16 to 25 years in the United States. Sex Transm Dis (2007) 0.94
Evaluation of a community-based organization's intervention to reduce the incidence of sexually transmitted diseases: a randomized, controlled trial. South Med J (2003) 0.93
Chlamydia screening in a Health Plan before and after a national performance measure introduction. Obstet Gynecol (2005) 0.91
HIV genital shedding and safety of Carraguard use by HIV-infected women: a crossover trial in Thailand. AIDS (2010) 0.91
Evaluation of an innovative internet-based partner notification program for early syphilis case management, Washington, DC, January 2007-June 2008. Sex Transm Dis (2010) 0.90
Insurance and billing concerns among patients seeking free and confidential sexually transmitted disease care: New York City sexually transmitted disease clinics 2012. Sex Transm Dis (2014) 0.89
Prevalence of genital warts among sexually transmitted disease clinic patients-sexually transmitted disease surveillance network, United States, January 2010 to December 2011. Sex Transm Dis (2014) 0.89
Anal intercourse among female sex workers in East Africa is associated with other high-risk behaviours for HIV. Sex Health (2011) 0.89
Prevalence of adult male circumcision in the general population and a population at increased risk for HIV/AIDS in New York City. Sex Transm Dis (2008) 0.89
Predictors of adherent use of diaphragms and microbicide gel in a four-arm, randomized pilot study among female sex workers in Madagascar. Sex Transm Dis (2009) 0.89
Predictors of index patient acceptance of expedited partner therapy for Chlamydia trachomatis infection and reasons for refusal, sexually transmitted disease clinics, New York City, 2011 to 2012. Sex Transm Dis (2014) 0.89
Lymphogranuloma venereum: old pathogen, new story. Curr Infect Dis Rep (2007) 0.89
Safety analysis of the diaphragm in combination with lubricant or acidifying microbicide gels: effects on markers of inflammation and innate immunity in cervicovaginal fluid. Am J Reprod Immunol (2009) 0.88